<DOC>
	<DOCNO>NCT00692315</DOCNO>
	<brief_summary>An open label trial undertaken 40 autistic child determine whether treatment metabolic precursor methylcobalamin folinic acid would improve plasma biomarkers oxidative stress measure core behavior use Vineland Adaptive Behavior Scales ( VABS ) . Metabolites involve methionine glutathione synthesis VABS behavior score measure three month intervention period . The result indicate pre-treatment metabolite autistic child significantly different value age-matched control child . The three month intervention result significant increase cysteine , cysteinylglycine , glutathione ( GSH , p &lt; 0.001 ) . The oxidized disulfide form glutathione ( GSSG ) decrease ( p &lt; 0.008 ) glutathione redox ratio ( GSH/GSSG ) increase treatment ( p &lt; 0.001 ) . Although significantly improve , metabolite remain control level intervention ( p &gt; 0.01 ) . Similarly , increase VABS composite score sub-scores Socialization , Communication , Daily Living Skills increase treatment ( p &lt; 0.007 ) also remain standard score .</brief_summary>
	<brief_title>Treating Oxidative Stress Children With Autism</brief_title>
	<detailed_description />
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<criteria>Clinical diagnosis Autistic Disorder DSMIV 299.0 CARS score &gt; 30 Primary genetic disease comorbid autism frequent seizure recent surgery active infection fever high dose vitamin/mineral supplement severe gastrointestinal symptom</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>glutathione</keyword>
	<keyword>methionine</keyword>
	<keyword>folinic acid</keyword>
	<keyword>redox</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>behavior</keyword>
</DOC>